Role of Octreotide in Preventing Pancreatic Fistula After Pancreaticoduodenectomy (PD) in Patients With Soft Pancreas
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
This randomized controlled trial (RCT) aims at assessing the influence of octreotide on
pancreatic fistula or complications following pancreatoduodenectomy in patients with soft
pancreas. Previously reported trials have included all types of pancreatic resections and
have include all types of pancreas and have shown no clearcut benefit of octreotide after
pancreaticoduodenectomy (PD). Soft pancreas and normal sized duct are the risk factors for
fistula following PD. This study's focus is on this select group of patients and aims to
assess the role of octreotide in patients with soft pancreas.